Benjamin L. Viglianti

Benjamin L. Viglianti

Radiology | Nuclear Medicine
1500 E Medical Center Dr
Floor B1 Reception C
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: April 09, 2026

Toward a Structured Imaging Reporting System for Kidney Masses: The Molecular Imaging Perspective on KI-RADS.

Toward a Structured Imaging Reporting System for Kidney Masses: The Molecular Imaging Perspective on KI-RADS.

Journal: Molecular imaging and biology
Published: March 01, 2026

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: February 06, 2026

A Scoping Review of the Challenges and Future Perspectives in the Use of Alpha-Emitters for Metastatic Ovarian Cancer.

A Scoping Review of the Challenges and Future Perspectives in the Use of Alpha-Emitters for Metastatic Ovarian Cancer.

Journal: Molecules (Basel, Switzerland)
Published: January 30, 2026

Performance of 99mTc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical Experience.

Performance of 99mTc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical Experience.

Journal: The Journal of urology
Published: December 23, 2025

Review of radiopharmaceutical therapy in prostate cancer.

Review of radiopharmaceutical therapy in prostate cancer.

Journal: Urologic oncology
Published: September 25, 2025

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 23, 2025

Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration.

Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration.

Journal: Clinical nuclear medicine
Published: September 19, 2025

Ethiodized oil interference of planned radioiodine therapy post thoracic duct embolization: report of 2 cases.

Ethiodized oil interference of planned radioiodine therapy post thoracic duct embolization: report of 2 cases.

Journal: JCEM case reports
Published: August 15, 2025

Simultaneous Presentation of Post-Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic Conundrum.

Simultaneous Presentation of Post-Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic Conundrum.

Journal: Case reports in gastrointestinal medicine
Published: June 24, 2025

Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types.

Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types.

Journal: Diagnostic and interventional imaging
Published: May 27, 2025

Posology for 177Lu-DOTATATE Therapy in Neuroendocrine Tumor: Effectiveness of Dose Reduction and Cycle Delay for Improving Therapy Tolerability.

Posology for 177Lu-DOTATATE Therapy in Neuroendocrine Tumor: Effectiveness of Dose Reduction and Cycle Delay for Improving Therapy Tolerability.

Journal: Clinical nuclear medicine
Published: May 18, 2025
Showing 1-12 of 66

Last Updated: 09/26/2026